Last reviewed · How we verify

ATM FOG in PD — Competitive Intelligence Brief

ATM FOG in PD (ATM FOG in PD) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neurology.

phase 3 Neurology Small molecule Live · refreshed every 30 min

Target snapshot

ATM FOG in PD (ATM FOG in PD) — Medical University of South Carolina. ATM FOG is a fog inhalation formulation designed to deliver atomoxetine or a related compound directly to the lungs for potential neuroprotective effects in Parkinson's disease.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ATM FOG in PD TARGET ATM FOG in PD Medical University of South Carolina phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ATM FOG in PD — Competitive Intelligence Brief. https://druglandscape.com/ci/atm-fog-in-pd. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: